AI assistant
Sending…
Sopharma AD — Earnings Release 2023
Apr 20, 2023
2543_rns_2023-04-20_c9027294-81c9-4b6b-aefe-675e948d5c9b.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report №19/ 2023 Dated April 20, 2023
NOTIFICATION
"Sopharma" AD (the Company) notifies that for March 2023 the Company recorded an increase in sales of 127% compared to the same month of the previous year, incl. 3% increase in domestic sales and 426% increase in export sales due to the low base in the previous period due to the collapse of sales in the main markets as a result of the conflict between Russia and Ukraine.
For the first three months of 2023, sales increased by a total of 45%, incl. 1% increase of sales for the domestic market and 97% increase in export sales.
Ognian Donev
More from Sopharma AD
Regulatory Filings
2026
May 29
Transaction in Own Shares
2026
May 29
Transaction in Own Shares
2026
May 28
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Transaction in Own Shares
2026
May 19